An overview of the utilization and cost for selected oral antineoplastic agents, with discussion regarding oncology in general, as well as the topic of adherence.
Marina L. Sehman, PharmD, RPh
Advertisement
Articles by Marina L. Sehman, PharmD, RPh
Advertisement
Latest Updated Articles
- Oral Oncology: Utilization of Selected Oral Antineoplastic Enzyme Inhibitor Agents
Published: August 2nd 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Updated Indication for Upadacitinib in Patients With IBD
2
CDC Layoffs Raise Questions About the Future of Public Health Surveillance
3
From $200,000 in Student Loan Debt to Becoming a 7-Figure Pharmacist
4
FDA Updates Boxed Warning for Cilta-Cel Following Reports of Immune Effector Cell–Associated Enterocolitis
5
